Leerink Partners Downgrades Centessa Pharmaceuticals (CNTA) to Market Perform

April 1, 2026 6:21 AM

Leerink Partners analyst David Risinger downgraded Centessa Pharmaceuticals (NASDAQ: CNTA) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found